Voluntary recall of infant formula initiated

Danny Federico
ECB Publishing, Inc.

Perrigo Company, plc has announced a voluntary recall of 16,500 cans of its private label Premium Infant Formula with milk-based iron powder. The recall, which affects three specific lot numbers, was initiated after routine testing found vitamin D levels in the formula that exceeded the maximum allowable limit. The affected products were shipped to HEB Grocery Company, LP, in Texas and to CVS locations in California, Florida, Indiana, Michigan, Missouri, New Jersey, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas and Virginia. This recall does not impact any other products or retailers.
The recall was carried out in coordination with the US Food and Drug Administration (FDA). Perrigo confirmed that no adverse events have been reported to date in connection with the increased vitamin D levels in the recalled products.
According to Perrigo, it is unlikely that the majority of infants who consumed the affected formulas will experience adverse health effects. However, the company cautions that a small group of infants with special vulnerabilities, such as impaired kidney function, may experience health complications from elevated vitamin D levels. Parents and caregivers are advised to check the lot numbers on the bottom of the packaging to determine if they have purchased the recalled product. If they have any concerns, they are advised to consult their doctor.
The recalled batch numbers are as follows:

Product delivery to CVS from February 6, 2024:
Batch code: T11LMYC – USE UNTIL 11.11.2025
(Material: 975261, UPC: 050428318034)

Product delivery to HEB Grocery Company, LP beginning February 2, 2024:
Batch code: T11LMXC – USE UNTIL 11.11.2025
Batch code: T09LMXC – USE UNTIL 09.11.2025
(Material: 788362, UPC: 041220164578)
Perrigo has notified HEB and CVS and asked them to review their retail and warehouse inventory and isolate any affected products.
Consumers who purchased the recalled infant formulas are asked to contact Perrigo Consumer Affairs at 1 (800) 538-9543 for more information. In addition, any adverse reactions observed in infants using the product should be reported to FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htm.